US 7109303
Modified cytokines for use in cancer therapy
granted A61KA61K2039/505A61K31/70
Quick answer
US patent 7109303 (Modified cytokines for use in cancer therapy) held by FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
- Grant date
- Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K31/70, A61K38/191, A61K47/6425